Evofem Biosciences Depreciation & Amortization 2011-2026 | EVFM

Annual Depreciation & Amortization Evofem Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
19 K	30 K	477 K	1.02 M	1.02 M	302 K	263 K	262 K	244 K	92 K	58.4 K	17.7 K	72.2 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.02 M	17.7 K	298 K

Quarterly Depreciation & Amortization Evofem Biosciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
80 K	107 K	6 K	-	301 K	-	12 K	-	500 K	200 K	245 K	-	765 K	515 K	265 K	-	738 K	470 K	195 K	-	181 K	123 K	69 K	-	198 K	132 K	66 K	-	196 K	131 K	65 K	-	179 K	113 K	48 K	-	52.9 K	35.4 K	17.8 K	-	40.6 K	22.9 K	3.8 K	-	12.7 K	8.61 K	4.98 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
765 K	3.8 K	174 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Amgen AMGN	5.17 B	$ 350.12	2.98 %	$ 188 B	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	57.3 M	$ 12.68	2.92 %	$ 3.97 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Arcutis Biotherapeutics ARQT	700 K	$ 24.48	5.18 %	$ 3.11 B	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	8.3 M	$ 1.5	9.93 %	$ 399 M	Britain
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.68	4.28 %	$ 16.8 M	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
Cabaletta Bio CABA	1.65 M	$ 3.05	-0.65 %	$ 306 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 3.1	2.31 %	$ 6.75 B	Israel
Cerus Corporation CERS	1.43 M	$ 1.92	4.08 %	$ 366 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	1.48 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	1.95 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	214 K	$ 2.81	2.18 %	$ 7.33 M	USA
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	4.63 M	-	-	$ 2.02 B	USA
Cyclerion Therapeutics CYCN	65 K	$ 3.43	-1.43 %	$ 8.64 M	USA